Tilray | TRLY - Equity Capital And Reserves

Stock Price
9.63
Daily Change
-0.80 -7.67%
Monthly
-24.88%
Yearly
533.55%
Q1 Forecast
9.94

Tilray reported $1.51B in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.





Equity Capital And Reserves Change Date
Acasti Pharma USD 62.82M 732K Sep/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Cronos Group USD 1.08B 214K Sep/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Moderna USD 9.33B 69M Sep/2025
Organigram Holdings CAD 349.13M 36.37M Sep/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Tilray USD 1.51B 1.22B Mar/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025